You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. X-Ray Detectors for Synchrotron-Based Structural Biology

    SBC: AREA DETECTOR SYSTEMS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Development is proposed of an x-ray Pixel Array Detector (PAD) consisting approximately of 2,000 x 2,000 pixels to enhance macromolecular crystallographic data collection at synchrotron sources. A PAD consists of an x-ray sensing integrated circuit layer bonded to a pixel electronics layer such that each pixel has its own processing electronics. PADs promise t ...

    SBIR Phase II 2003 Department of Health and Human Services
  2. A Tunable, Tabletop, Synchrotron Light Source

    SBC: LYNCEAN TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase II 2003 Department of Health and Human Services
  3. Development of Fludase for Prevention of Influenza

    SBC: Nexbio, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Influenza is characterized by recurrent annual epidemics and periodic major worldwide pandemics. Because of the high disease-related morbidity and mortality, direct and indirect socio-economic impacts of influenza are enormous. In the last 100 years, there have been 3 major influenza pandemics. It has been about thirty years since the last pandemic. A new pand ...

    SBIR Phase II 2005 Department of Health and Human Services
  4. Prophylactic Anthrax Toxin Vaccine

    SBC: VICAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Vical Inc. seeks SBIR Phase II funding to develop and produce a licensable prophylactic anthrax vaccine. This project will move on an accelerated but realistic timeline with plans for human clinical trials to begin in September 2003. Although many candidate vaccines are being studied for anthrax prevention or post-exposure prophylaxis, the Vical approach has ...

    STTR Phase II 2003 Department of Health and Human Services
  5. Scorpius® Suborbital Rocket (SR-M) Expendable Vehicle Technology

    SBC: Microcosm, Inc.            Topic: AF04199

    Microcosm, Inc. is proposing to complete the buildup of the suborbital rocket (SR-M) vehicle and launch this vehicle within twelve months of the authority to proceed. The suborbital rocket SR-M can carry up to a 2,400 pound payload. The SR-M offers considerable flexibility and performance while achieving low mission cost. Variations of the vehicle can be created to form the core of various mission ...

    SBIR Phase II 2005 Department of DefenseAir Force
  6. Light Weight, Low Volume Deployable Antenna Structures

    SBC: L'GARDE INC.            Topic: AF04018

    Efficient structures requiring low-volume and low-mass have an important role in future military and commercial missions especially in theatre of space. These structures can increase the peformance of applications requiring large apertures such as space-based intelligence, surveillance, and reconnasissance systems. These structures can also be efficient as inflatable, deployable target simulator ...

    SBIR Phase II 2005 Department of DefenseAir Force
  7. Scalable, Multi-Paradigm Modeling Framework for accurate analysis of large, next generation networks

    SBC: Scalable Network Technologies, Inc.            Topic: A04132

    Hardware- and software-in-the-loop models offer an efficient and scalable approach for analysis of distributed C4ISR applications executing on heterogeneous networks. A virtual laboratory that integrates a physical test-bed with a much larger simulated network, can incorporate realistic physical effects while simultaneously scaling the analysis to much larger networks than are physically accessi ...

    SBIR Phase II 2005 Department of DefenseArmy
  8. CMV Immunotherapeutic Vaccine

    SBC: VICAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Vical Inc. of San Diego, Ca. is the largest GMP manufacturer of plasmid DNA for vaccine clinical trials in the world. We have manufactured GMP plasmid DNA vaccines that are being used or entering clinical trials for HIV (in the US and China), malaria (up to 9 plasmids), Ebola, WNV, and SARS. Vical has undertaken an internal Product Development Program that focu ...

    SBIR Phase II 2005 Department of Health and Human Services
  9. Advancing the Frontiers of Broad Band CEM for Target Modeling Applications

    SBC: Hypercomp, Inc.            Topic: N/A

    HyPerComp, a premiere developer of innovative and highly scalable computational environments for time-domain electromagnetics, proposes to develop, demonstrate and deliver the next generation TEMPUS (Time-Domain EM Parallel Unstructured Simulator)environment to perform cost-effective and routine X-band to 20 GHz computations for full-scale targets with general materials to provide highly accurate ...

    SBIR Phase II 2001 Department of DefenseAir Force
  10. Genome-Wide Scan for Alzheimer's Associated Genes

    SBC: Perlegen Sciences, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this study is to identify the genetic determinants of late-onset Alzheimer's disease (AD). The proposed study uses Perlegen Sciences' high-density oligonucleotide array-based genotyping platform to genotype over 1.5 million single nucleotide polymorphisms (SNPs) across the genome in the context of a whole-genome association study of late-onset AD. ...

    SBIR Phase II 2005 Department of Health and Human Services
US Flag An Official Website of the United States Government